IL10 and pulmonary arterial hypertension: In a mouse model of congenital diaphragmatic hernia that is notable for developing clinical and histologic pulmonary hypertension at 4 weeks of life, we show that treatment with an IL-10/HA hydrogel reduced the perivascular inflammatory cell burden and lowered pulmonary vascular resistance (unpublished data).